0001209191-19-061939.txt : 20191226 0001209191-19-061939.hdr.sgml : 20191226 20191226162550 ACCESSION NUMBER: 0001209191-19-061939 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191220 FILED AS OF DATE: 20191226 DATE AS OF CHANGE: 20191226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cotroneo Pat CENTRAL INDEX KEY: 0001621334 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36740 FILM NUMBER: 191310814 MAIL ADDRESS: STREET 1: C/O FIBROGEN, INC. STREET 2: 409 ILLINOIS ST., CITY: SAN FRANCISCO STATE: CA ZIP: 94158 FORMER NAME: FORMER CONFORMED NAME: Controneo Pat DATE OF NAME CHANGE: 20141002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIBROGEN INC CENTRAL INDEX KEY: 0000921299 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-978-1200 MAIL ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-12-20 0 0000921299 FIBROGEN INC FGEN 0001621334 Cotroneo Pat C/O FIBROGEN, INC. 409 ILLINOIS ST. SAN FRANCISCO CA 94158 0 1 0 0 SVP, Finance and CFO Common Stock 2019-12-20 4 M 0 18000 3.50 A 271788 D Common Stock 2019-12-20 4 M 0 21000 5.95 A 292788 D Common Stock 2019-12-20 4 M 0 17254 14.575 A 310042 D Common Stock 2019-12-20 4 S 0 46727 45.51 D 263315 D Common Stock 2019-12-20 4 S 0 12729 46.27 D 250586 D Stock Option (Right to Buy) 3.50 2019-12-20 4 M 0 18000 0.00 D 2021-06-07 Common Stock 18000 0 D Stock Optin (Right to Buy) 5.95 2019-12-20 4 M 0 21000 0.00 D 2022-06-27 Common Stock 21000 0 D Stock Option (Right to Buy) 14.575 2019-12-20 4 M 0 17254 0.00 D 2024-03-19 Common Stock 17254 0 D Shares sold pursuant to a 10b5-1 plan. The shares were sold at prices ranging from $44.91 to $45.90. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $45.91 to $46.44. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Fully vested. /s/ Dorothy Pacini, Attorney-in-fact 2019-12-26